Why the study?
Does transvenous endocardial pacing with the SelectSecure 3830 lead provide safe and effective pacing in infant patients with high-degree AVB?
Population
Two infant patients
Comparison
Transvenous endocardial pacing using the SelectSecure 3830 lead
Design
Case series and literature review
Follow-up
5 years and 3 years, respectively
Authors
Loading...
Supports thin-lead pacing feasibility in pediatric CHD; leaves open safety and durability in larger prospective series.
Does transvenous endocardial pacing with the SelectSecure 3830 lead provide safe and effective pacing in infant patients with high-degree AVB?
Transvenous endocardial pacing with the SelectSecure 3830 lead is a safe and viable option for infants with high-degree AVB, providing stable long-term pacing parameters.
Yang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: